Current diagnosis and screening of hydroxychloroquine retinopathy
Archives of Ophthalmological Research · 2024
DOI: 10.51271/aor-0013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Ophthalmological Research, 2024. Verfasst von Hüseyin Egemen Köse und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Hydroxychloroquine-associated retinopathy is an important cause of progressive visual loss that is increasingly being diagnosed with the growing use of hydroxychloroquine and modern imaging techniques. Hydroxychloroquine acts through complex mechanisms and is commonly used to treat rheumatological and dermatological diseases. Optical coherence tomography, fundus autofluorescence, and automated perimetry are commonly used in retinal clinics for the diagnosis and monitoring of hydroxychloroquine-associated retinopathy. Owing to the potential for irreversible central visual loss with the development of retinopathy, early detection of toxicity is crucial. Advances in technology, wide-field imaging devices, new optical coherence tomography techniques and parameters, fundus autofluorescence techniques, and imaging methods such as optical coherence tomography angiography offer promise for the early detection of toxicity.
Zitieren
APA
Köse, H. E., & Çıtırık, M. (2024). Current diagnosis and screening of hydroxychloroquine retinopathy. Archives of Ophthalmological Research. https://doi.org/10.51271/aor-0013
Vancouver
Köse HE, Çıtırık M. Current diagnosis and screening of hydroxychloroquine retinopathy. Archives of Ophthalmological Research. 2024. doi:10.51271/aor-0013
BibTeX
@article{Kse2024,
author = {Köse, Hüseyin Egemen and Çıtırık, Mehmet},
title = {Current diagnosis and screening of hydroxychloroquine retinopathy},
journal = {Archives of Ophthalmological Research},
year = {2024},
doi = {10.51271/aor-0013}
}
EUVIMED